The Motley Fool

Key Data Points

Primary metrics and data points about Galectin Therapeutics Inc..
Current Price: $2.57
Prev Close: $2.57
Open: $2.59
Bid: $0.50
Ask: $2.93
Day's Range: $2.56 - $2.69
52wk Range: $2.50 - $6.70
Volume: 24,810
Avg Vol 170,616
Market Cap: $61M
P/E (ttm): -3.48
EPS (ttm): ($0.73)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Galectin Therapeutics Inc..

A development stage pharmaceutical company engaged in the discovery, development and commercialization of carbohydrate-based therapeutic compounds for advanced treatment of cancer, liver, microbial, cardiovascular and inflammatory diseases.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

GALT vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Galectin Therapeutics Inc..
CAPS Rating 1 out of 5
 
56 Outperform
46 Underperform
CAPS All Stars
 
11 Outperform
34 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Theodore D. Zucconi, CEO

0% Approve

Based on 0 Ratings

Powered by

More Details about Galectin Therapeutics Inc.

Primary metrics and data points about Galectin Therapeutics Inc..